We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-3.2%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$745B
AUM Growth
+$33.9B
Cap. Flow
+$45.4B
Cap. Flow %
6.09%
Top 10 Hldgs %
31.69%
Holding
14,193
New
1,741
Increased
5,205
Reduced
5,319
Closed
1,559

Top Sells

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$2.17B
2
AMZN icon
Amazon
AMZN
+$1.98B
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.79B
4
NVDA icon
NVIDIA
NVDA
+$1.18B
5
WFC icon
Wells Fargo
WFC
+$827M

Sector Composition

Rank Sector Weight
1 Technology 1.89%
2 Consumer Discretionary 1.29%
3 Communication Services 0.93%
4 Healthcare 0.89%
5 Financials 0.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NBEV
12301
CALL
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$47K ﹤0.01%
34,100
-60,200
-64% -$110K
AVTX icon
12302
Avalo Therapeutics
AVTX
$1.06B
$46K ﹤0.01%
7
-37
-84% -$300K
ELVN icon
12303
Enliven Therapeutics
ELVN
$4.47B
$46K ﹤0.01%
+2,837
New +$58.9K
IMNN icon
12304
PUT
Imunon
IMNN
$9.31M
$46K ﹤0.01%
252
-632
-71% -$131K
NINE
12305
DELISTED
Nine Energy Service
NINE
$46K ﹤0.01%
+25,075
New +$56.2K
RKDA icon
12306
PUT
Arcadia Biosciences
RKDA
$1.18M
$46K ﹤0.01%
558
-783
-58% -$73.5K
BEST
12307
PUT
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
$46K ﹤0.01%
1,385
-9,040
-87% -$236K
TCDA
12308
PUT
DELISTED
Tricida, Inc. Common Stock
TCDA
$46K ﹤0.01%
10,000
-34,200
-77% -$142K
NH
12309
CALL
DELISTED
NantHealth, Inc
NH
$46K ﹤0.01%
1,887
-2,513
-57% -$75.5K
MLSS icon
12310
Milestone Scientific
MLSS
$43M
$45K ﹤0.01%
23,897
-31,717
-57% -$58.7K
SRTS icon
12311
CALL
Sensus Healthcare
SRTS
$55.3M
$45K ﹤0.01%
+12,600
New +$46.1K
LJPC
12312
CALL
DELISTED
La Jolla Pharmaceutical Company
LJPC
$45K ﹤0.01%
+11,400
New +$45.2K
ABEO icon
12313
CALL
Abeona Therapeutics
ABEO
$355M
$44K ﹤0.01%
+1,572
New +$50.3K
GYRE icon
12314
PUT
Gyre Therapeutics
GYRE
$708M
$44K ﹤0.01%
+1,427
New +$47K
LITS
12315
PUT
Lite Strategy Inc
LITS
$35.7M
$44K ﹤0.01%
800
+45
+6% +$2.48K
PIIIW icon
12316
P3 Health Partners Inc Warrant
PIIIW
$132K
$44K ﹤0.01%
50,000
TTI icon
12317
PUT
TETRA Technologies
TTI
$1B
$44K ﹤0.01%
14,100
-106,700
-88% -$342K
VATE icon
12318
CALL
INNOVATE Corp
VATE
$105M
$44K ﹤0.01%
+1,070
New +$40K
BFIIW
12319
DELISTED
BurgerFi International, Inc. Warrant
BFIIW
$44K ﹤0.01%
27,291
BURU.WS
12320
DELISTED
Nuburu, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
BURU.WS
$44K ﹤0.01%
75,000
IPOD.WS
12321
DELISTED
Social Capital Hedosophia Holdings Corp. IV Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
IPOD.WS
$44K ﹤0.01%
24,954
AUTO
12322
PUT
DELISTED
AutoWeb, Inc. Common Stock
AUTO
$44K ﹤0.01%
15,600
+2,800
+22% +$7.89K
ONCS
12323
PUT
DELISTED
OncoSec Medical Incorporated
ONCS
$44K ﹤0.01%
+941
New +$47.7K
GORO icon
12324
PUT
Goldgroup Mining
GORO
$292M
$43K ﹤0.01%
27,400
-24,700
-47% -$46.9K
KRMD icon
12325
KORU Medical Systems
KRMD
$148M
$43K ﹤0.01%
15,251
-14,420
-49% -$47.7K

Similar funds

Jeff Yass's Q3 2021 Portfolio in Review

As of Q3 2021, Jeff Yass held 14,193 positions worth $745B, up 4.8% from $712B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jeff Yass deployed $45.4B of net new capital in Q3 2021, opening 1,741 new positions and adding to 5,205 existing holdings. Its largest new stake was InMode: 613,660 shares worth $48.9M.

By sector, the portfolio is most concentrated in Technology at 1.9% of assets, down from 1.9% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Walt Disney, an estimated $2.17B trimmed.

  • Jeff Yass's largest Q3 2021 buy was InMode: 613,660 shares worth $48.9M.
  • Jeff Yass added most to Zoom in Q3 2021, an estimated $834M increase.
  • Jeff Yass's biggest Q3 2021 reduction was Walt Disney, cutting an estimated $2.17B.
  • Jeff Yass fully exited PRA Health Sciences, Inc. in Q3 2021, selling an estimated $103M.
  • Jeff Yass's ten largest holdings make up 32% of its $745B portfolio in Q3 2021.
  • Jeff Yass opened 1,741 new positions and closed 1,559 in Q3 2021.
  • Jeff Yass's portfolio value rose 4.8% quarter-over-quarter to $745B.

Based on Susquehanna International Group's 13F filing for Q3 2021, filed 15 Nov 2021.